Market Cap ₹225 Cr.
Stock P/E 7.7
P/B 2.9
Current Price ₹237
Book Value ₹ 82.7
Face Value 10
52W High ₹365
Dividend Yield 0%
52W Low ₹ 178.6
Ovobel Foods Ltd is engaged inside the manufacture of egg powder and frozen egg. The Company offers egg-powder and egg-liquid. It offers merchandise, including Hen Whole Egg Powder, that is utilized in bakery merchandise, pasta premix, omelettes and pancake premixes; Hen Egg Yolk Powder, that is used in doughnut premix, bakery products, pasta premix, mayonnaise, biscuits, cookies and wafers; Hen Egg Albumen Powder (High whip) Stabilized, which is utilized in nougat, chocolate merchandise, meringues and muscle building health foods; Hen Egg Albumen Powder (High Gel) Stabilized, that is used as a binder in meat and fish merchandise, macaroni and puree; Pasteurised Frozen Hen Whole Egg, that's utilized in food provider application, flight kitchens, soups, confectionery and burger patties; Pasteurised Frozen Hen Egg Yolk, that is used in salad dressings, sauces, ice-cream, bakery products and health beverages, and Pasteurised frozen Hen Egg Albumen, that is utilized in sugary merchandise and meat products.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 25 | 30 | 34 | 36 | 49 | 60 | 55 | 49 | 46 | 51 |
| Other Income | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Total Income | 26 | 31 | 34 | 37 | 49 | 61 | 56 | 50 | 47 | 52 |
| Total Expenditure | 29 | 32 | 33 | 31 | 43 | 46 | 42 | 36 | 35 | 51 |
| Operating Profit | -4 | -1 | 1 | 5 | 5 | 14 | 14 | 15 | 12 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -4 | -1 | 0 | 5 | 5 | 14 | 14 | 14 | 12 | 1 |
| Provision for Tax | -0 | 0 | 0 | 0 | 1 | 3 | 4 | 3 | 3 | 0 |
| Profit After Tax | -4 | -1 | -0 | 5 | 4 | 11 | 10 | 11 | 9 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -4 | -1 | -0 | 5 | 4 | 11 | 10 | 11 | 9 | 0 |
| Adjusted Earnings Per Share | -3.4 | -1.3 | -0.1 | 5.4 | 3.7 | 11.7 | 10 | 11.1 | 9.1 | 0.4 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 83 | 105 | 98 | 106 | 75 | 83 | 97 | 109 | 111 | 125 | 221 | 201 |
| Other Income | 4 | 7 | 8 | 10 | 5 | 16 | 15 | 8 | 6 | 2 | 3 | 4 |
| Total Income | 88 | 112 | 107 | 115 | 81 | 100 | 112 | 117 | 117 | 127 | 225 | 205 |
| Total Expenditure | 86 | 93 | 92 | 107 | 81 | 92 | 102 | 111 | 117 | 125 | 170 | 164 |
| Operating Profit | 2 | 20 | 15 | 8 | -1 | 7 | 10 | 6 | -1 | 2 | 55 | 42 |
| Interest | 2 | 23 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -4 | 13 | 6 | -3 | 5 | 8 | 4 | -3 | 0 | 53 | 41 |
| Provision for Tax | 0 | 0 | 4 | 2 | 1 | 1 | 3 | 1 | -1 | 0 | 14 | 10 |
| Profit After Tax | -0 | -4 | 9 | 4 | -4 | 5 | 6 | 3 | -2 | 0 | 39 | 30 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -0 | -4 | 9 | 4 | -4 | 5 | 6 | 3 | -2 | 0 | 39 | 30 |
| Adjusted Earnings Per Share | -0.3 | -3.7 | 8.8 | 4 | -3.3 | 4.3 | 5.4 | 2.6 | -1.7 | 0 | 40.9 | 30.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 77% | 27% | 22% | 10% |
| Operating Profit CAGR | 2650% | 109% | 51% | 39% |
| PAT CAGR | 0% | 135% | 51% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 31% | 96% | 67% | NA% |
| ROE Average | 98% | 30% | 27% | 48% |
| ROCE Average | 80% | 26% | 25% | 45% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | -1 | -4 | 10 | 14 | 10 | 15 | 20 | 23 | 21 | 20 | 59 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 2 |
| Other Non-Current Liabilities | 1 | 1 | -0 | 0 | -1 | -1 | -0 | 0 | -1 | -1 | -0 |
| Total Current Liabilities | 22 | 40 | 44 | 44 | 39 | 27 | 16 | 18 | 21 | 32 | 39 |
| Total Liabilities | 23 | 37 | 55 | 60 | 50 | 41 | 36 | 41 | 42 | 55 | 100 |
| Fixed Assets | 2 | 2 | 2 | 3 | 5 | 4 | 4 | 3 | 4 | 3 | 3 |
| Other Non-Current Assets | 0 | 1 | 1 | 0 | 3 | 2 | 1 | 2 | 1 | 1 | 10 |
| Total Current Assets | 21 | 35 | 52 | 57 | 42 | 35 | 32 | 36 | 38 | 51 | 87 |
| Total Assets | 23 | 37 | 55 | 60 | 50 | 41 | 36 | 41 | 42 | 55 | 100 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | -13 | 0 | 5 | 3 | 6 | 6 | 6 | 8 | 1 | 0 | 6 |
| Cash Flow from Operating Activities | 10 | 12 | 8 | -2 | -3 | 1 | 3 | 1 | -1 | -5 | 41 |
| Cash Flow from Investing Activities | 3 | -6 | -7 | 1 | 4 | 0 | -0 | -0 | -2 | -0 | -41 |
| Cash Flow from Financing Activities | -1 | -2 | -2 | -1 | -1 | -1 | -1 | -0 | 3 | 11 | 0 |
| Net Cash Inflow / Outflow | 13 | 4 | -1 | -3 | -0 | 0 | 1 | 0 | -0 | 6 | 0 |
| Closing Cash & Cash Equivalent | 0 | 5 | 3 | 0 | 6 | 6 | 8 | 8 | 0 | 6 | 6 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.27 | -3.71 | 8.78 | 3.98 | -3.34 | 4.31 | 5.38 | 2.59 | -1.72 | 0.02 | 40.86 |
| CEPS(Rs) | 0.17 | -3.48 | 9.03 | 4.51 | -2.35 | 5.52 | 6.32 | 3.58 | -0.89 | 0.97 | 41.67 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -0.52 | -4.23 | 9.25 | 13.23 | 9.67 | 13.92 | 19.32 | 21.59 | 19.86 | 21.05 | 62.01 |
| Core EBITDA Margin(%) | -3.07 | 11.85 | 6.54 | -1.14 | -7.98 | -10.65 | -4.68 | -2.04 | -5.72 | -0.06 | 23.21 |
| EBIT Margin(%) | 1.51 | 18.25 | 14.82 | 7.31 | -2.48 | 7.42 | 9.54 | 4.38 | -1.29 | 0.77 | 24.41 |
| Pre Tax Margin(%) | -0.35 | -3.68 | 13.58 | 5.8 | -3.82 | 6.3 | 8.64 | 3.54 | -2.33 | 0.1 | 23.76 |
| PAT Margin (%) | -0.35 | -3.68 | 9.32 | 3.93 | -4.61 | 5.42 | 5.81 | 2.5 | -1.63 | 0.01 | 17.54 |
| Cash Profit Margin (%) | 0.22 | -3.45 | 9.59 | 4.45 | -3.25 | 6.93 | 6.82 | 3.46 | -0.84 | 0.74 | 17.89 |
| ROA(%) | -1.36 | -12.82 | 20.05 | 7.32 | -6.4 | 9.95 | 14.6 | 7.06 | -4.39 | 0.04 | 50.31 |
| ROE(%) | 0 | 0 | 350.02 | 35.42 | -29.2 | 36.58 | 32.39 | 12.66 | -8.32 | 0.08 | 98.39 |
| ROCE(%) | 11.47 | 218.72 | 89.75 | 28.61 | -7.4 | 25.08 | 31.74 | 14.29 | -4.02 | 2.32 | 80.29 |
| Receivable days | 38.02 | 36.67 | 44.06 | 51.72 | 67.98 | 50.03 | 35.55 | 24.38 | 27.96 | 30.62 | 24.27 |
| Inventory Days | 19.9 | 19.88 | 23.36 | 24.52 | 49.71 | 47.61 | 37.04 | 40.81 | 43.12 | 44.07 | 29.47 |
| Payable days | 34.12 | 33.83 | 21.27 | 15.05 | 13.5 | 10.38 | 13.76 | 10.72 | 9.71 | 11 | 7.33 |
| PER(x) | 0 | 0 | 0 | 0 | 0 | 5.03 | 2.52 | 6.6 | 0 | 1293.3 | 3.2 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 2.84 | 1.56 | 0.7 | 0.79 | 1.64 | 1.1 | 2.11 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.21 | 0.06 | 0.05 | 0.11 | 0.47 | 0.34 | 0.18 | 0.2 | 0.37 | 0.27 | 0.47 |
| EV/Core EBITDA(x) | 10.06 | 0.32 | 0.35 | 1.43 | -41.82 | 3.78 | 1.75 | 3.77 | -73.8 | 18.17 | 1.92 |
| Net Sales Growth(%) | 22.31 | 26.59 | -6.75 | 7.4 | -28.63 | 10.71 | 16.64 | 11.72 | 1.86 | 12.97 | 76.95 |
| EBIT Growth(%) | 737.09 | 1438.25 | -24.21 | -46.89 | -124.29 | 428.05 | 49.67 | -48.66 | -130.05 | 167.63 | 5479.95 |
| PAT Growth(%) | 81.09 | -1253.5 | 336.69 | -54.66 | -183.97 | 229.03 | 24.81 | -51.9 | -166.56 | 100.94 | 0 |
| EPS Growth(%) | 81.09 | -1253.5 | 336.71 | -54.66 | -183.97 | 229.02 | 24.81 | -51.9 | -166.56 | 101.04 | 0 |
| Debt/Equity(x) | -21.48 | -2.46 | 1.69 | 1.03 | 1.25 | 0.82 | 0.57 | 0.53 | 0.75 | 1.35 | 0.49 |
| Current Ratio(x) | 0.93 | 0.87 | 1.18 | 1.29 | 1.08 | 1.33 | 1.97 | 2 | 1.75 | 1.6 | 2.24 |
| Quick Ratio(x) | 0.7 | 0.71 | 1.04 | 1.1 | 0.76 | 0.99 | 1.32 | 1.24 | 1.17 | 1.05 | 1.78 |
| Interest Cover(x) | 0.81 | 0.83 | 12.01 | 4.83 | -1.85 | 6.67 | 10.62 | 5.2 | -1.25 | 1.15 | 37.65 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.44 | 0.52 | 0.82 | 0.68 | 0.46 | 1.11 | 0.23 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.78 | 68.78 | 69.25 | 69.25 | 69.25 | 76.54 | 75.08 | 70.13 | 68.71 | 68.71 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 9.53 | 9.53 | 9.53 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 21.69 | 21.69 | 21.22 | 30.75 | 30.75 | 23.46 | 24.91 | 29.86 | 31.29 | 31.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.72 | 0.72 | 0.73 | 0.73 | 0.73 | 0.73 | 0.71 | 0.67 | 0.65 | 0.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.23 | 0.23 | 0.22 | 0.32 | 0.32 | 0.22 | 0.24 | 0.28 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.05 | 1.05 | 1.05 | 1.05 | 1.05 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
